Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma

OBJECTIVES: Timolol maleate has been reported to be a safer intraocular pressure (IOP) lowering treatment than latanoprost. The United States Food and Drug Administration approved latanoprostene bunod, a nitric oxide-donating prodrug of latanoprost, for lowering IOP. This study compared the safety a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yulong, Liao, Yue, Nie, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Medicina / USP 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688071/
https://www.ncbi.nlm.nih.gov/pubmed/33263632
http://dx.doi.org/10.6061/clinics/2020/e1874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688071/
https://www.ncbi.nlm.nih.gov/pubmed/33263632
http://dx.doi.org/10.6061/clinics/2020/e1874

Ejemplares similares